Lantern Pharma a clinical stage oncology biotech leveraging A.I. and machine learning genomics company has selected REPROCELL Inc. to provide drug screening and drug sensitivity services. BELTSVILLE, MD.: REPROCELL Inc. a stem cell and drug discovery company has announced today that they have been selected by Lantern Pharma to provided preclinical screening and drug sensitivity for its portfolio of oncology drugs. The collaboration [...]

WESTFORD, MA / Hitachi High-Tech Analytical Science Corporation (Hitachi High-Tech Analytical Science), a Hitachi High-Technologies Corporation (TSE: 8036) wholly-owned subsidiary engaged in the manufacture and sales of analysis and measuring instruments, launches the OE750 - a ground-breaking new optical emission spectrometer for verifying demanding metals specifications in foundries and metal production. Complex supply chains and [...]

Merck today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. DARMSTADT, GERMANY License to accelerate research, enable testing and development of new drugs Merck, a leading science and technology company, today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR [...]

Global leader in liquid nitrogen storage systems expected to support growth, diversify revenue and reduce evo® manufacturing costs Preliminary 2020 revenue guidance of $50 - $56 Million Conference call begins today at 4:30 p.m. Eastern time BOTHELL, Wash. -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-class [...]

MOUNTAIN VIEW, Calif.--Takara Bio USA, Inc. (TBUSA) announced that its parent company, Takara Bio Inc., has launched the world’s first commercially available small intestinal epithelial cells derived from human induced pluripotent stem cells. The new Cellartis® Intestinal Epithelial Cells (from ChiPSC18) Kit was jointly developed when Takara Bio received a technology transfer from a differentiation induction method [...]

Next-generation, cost-effective solution for front- and back-side edits enables rapid prototyping PORTLAND, Ore. -- Circuit edit (CE) engineers, whether supporting designers or in service labs, who are looking for a cost-effective solution can increase their productivity with the next-generation Thermo Scientific Centrios circuit edit system. Announced today at the International Symposium for Testing and Failure Analysis (ISTFA) [...]

Leading immuno-oncology company adopts Genedata Biologics to support the discovery and development of TCRs for adoptive cell therapies and bispecific TCR molecules Basel, Switzerland Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Immatics Biotechnologies, a clinical-stage biopharmaceutical company developing T-cell receptor (TCR)-based cancer immunotherapies, has adopted Genedata Biologics® to streamline their R&D [...]

CHADDS FORD, Pa.--MOBILion Systems, Inc., a life science company developing an advanced analytical instrument platform that efficiently identifies the most challenging molecules to accelerate biologic drug development and improve diagnostic insights, today announced they raised $15.4 million in Series A financing. The round was led by Agilent Technologies, with participation from IP Group Inc., Hostplus, [...]

The recently launched sample mounting unit for the high-end time-resolved fluorescence spectrometer enables remote measurements From November 4 to 7, 2019, the lecturers and participants of the international course on “Principles and Applications of Time-resolved Fluorescence Spectroscopy” got a first look at PicoQuant’s FluoMic in action. This new add-on brings the accessibility and versatility of the time-resolved [...]

BOULDER, Colo. ​​​​InDevR, Inc., a biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, today announced that Dr. Barry Buckland is joining the company’s Board of Directors effective Jan. 1, 2019. Dr. Buckland has more than 30 years of real-world experience in addressing vaccine bioprocessing issues to the [...]